ARTICLE | Clinical News
GPI-15715 (PQ-1002): Began Phase I trial
December 18, 2000 8:00 AM UTC
Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. Product: GPI-15715 (PQ-1002) Business: Neurological Therapeutic category: Neurotransmission Target: Unknown Description: Water soluble prodrug form...